Inozyme Pharma (INZY) Stock Chart & Stock Price History → What President Biden's new law means for investors (From Stansberry Research) (Ad) Free INZY Stock Alerts $4.66 +0.06 (+1.30%) (As of 11:39 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Inozyme Pharma Stock Price Performance5 Day Performance-1.50%1 Month Performance+2.00%3 Month Performance-20.42%6 Month Performance+17.95%Year-To-Date Performance+7.98%1 Year Performance-27.56% Receive INZY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inozyme Pharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchWhat President Biden's new law means for investorsWhat's Got Musk, Bezos, and Gates So Excited? Billionaires are plowing millions of dollars into a new technology that early estimates say could generate more wealth than A.I. – and determine the future of companies like Microsoft. The problem? Most investors have no idea it's happening, or how to profit on it.This expert just went public with all the details, including which stocks to jump on immediately. INZY Stock Chart for Monday, May, 20, 2024 INZY Chart by TradingView Inozyme Pharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$4.73$4.60-2.75%$4.75$4.57240,183 shs$284.56 million05/16/2024$4.67$4.73+1.28%$4.74$4.59218,190 shs$292.58 million05/15/2024$4.63$4.67+0.86%$4.81$4.65343,297 shs$288.87 million05/14/2024$4.51$4.63+2.66%$4.72$4.58292,012 shs$286.41 million05/13/2024$4.54$4.51-0.66%$4.71$4.46471,710 shs$278.99 million05/10/2024$4.65$4.54-2.37%$4.65$4.46323,204 shs$280.83 million Get the Latest News and Ratings for INZY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inozyme Pharma and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$4.64$4.65+0.22%$4.69$4.59459,780 shs$287.65 million05/08/2024$4.60$4.64+0.87%$4.65$4.49392,061 shs$287.03 million05/07/2024$4.88$4.60-5.74%$4.84$4.54558,167 shs$284.56 million05/06/2024$4.74$4.88+2.95%$4.90$4.76354,520 shs$301.88 million05/03/2024$4.65$4.74+1.94%$4.84$4.69327,045 shs$293.22 million05/02/2024$4.61$4.65+0.87%$4.73$4.58567,812 shs$287.65 million05/01/2024$4.41$4.61+4.54%$4.72$4.35510,700 shs$285.18 million04/30/2024$4.42$4.41-0.23%$4.55$4.38638,147 shs$272.42 million04/29/2024$4.44$4.42-0.45%$4.57$4.40579,236 shs$273.02 million04/26/2024$4.33$4.44+2.54%$4.51$4.23511,357 shs$274.26 million04/25/2024$4.40$4.33-1.59%$4.49$4.18627,485 shs$267.46 million04/24/2024$4.40$4.40$4.49$4.35478,912 shs$271.79 million04/23/2024$4.39$4.40+0.23%$4.62$4.40742,550 shs$271.79 million04/22/2024$4.51$4.39-2.66%$4.57$4.39812,450 shs$271.17 million04/19/2024$4.58$4.51-1.53%$4.63$4.38591,071 shs$278.58 million04/18/2024$4.65$4.58-1.51%$4.82$4.57561,269 shs$282.91 million04/17/2024$4.85$4.65-4.12%$4.98$4.62408,248 shs$287.23 million04/16/2024$4.71$4.85+2.97%$4.99$4.60702,199 shs$299.59 million04/15/2024$5.14$4.71-8.37%$5.11$4.67739,530 shs$290.94 million04/12/2024$5.22$5.14-1.53%$5.21$4.89820,969 shs$317.50 million04/11/2024$5.24$5.22-0.38%$5.49$5.15728,241 shs$322.45 million04/10/2024$5.48$5.24-4.38%$5.30$5.101.28 million shs$323.68 million04/09/2024$5.87$5.48-6.64%$5.68$4.881.75 million shs$338.50 million04/08/2024$6.41$5.87-8.42%$7.01$5.761.84 million shs$362.59 million04/05/2024$6.49$6.41-1.23%$6.61$6.24749,321 shs$395.95 million04/04/2024$7.17$6.49-9.48%$7.31$6.441.12 million shs$400.89 million04/03/2024$6.93$7.17+3.46%$7.21$6.86814,990 shs$442.89 million04/02/2024$7.31$6.93-5.20%$7.31$6.84712,543 shs$428.07 million04/01/2024$7.66$7.31-4.57%$7.80$6.96934,661 shs$451.54 million03/29/2024$7.66$7.66$7.73$7.281.26 million shs$473.16 million03/28/2024$7.39$7.66+3.65%$7.73$7.281.26 million shs$473.16 million03/27/2024$6.78$7.39+9.00%$7.56$6.671.25 million shs$456.48 million03/26/2024$6.23$6.78+8.83%$7.28$6.361.73 million shs$418.80 million03/25/2024$5.80$6.23+7.41%$6.29$5.79715,807 shs$384.83 millionWarren Buffett's "mystery stock" (Ad)WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some 03/22/2024$5.87$5.80-1.19%$5.99$5.76539,681 shs$358.27 million03/21/2024$5.91$5.87-0.68%$6.13$5.86501,679 shs$362.59 million03/20/2024$5.69$5.91+3.87%$5.98$5.59659,902 shs$365.06 million03/19/2024$6.00$5.69-5.17%$5.99$5.67620,239 shs$351.47 million03/18/2024$5.89$6.00+1.87%$6.24$5.78696,794 shs$370.62 million03/15/2024$5.62$5.89+4.80%$5.97$5.58975,896 shs$363.83 million03/14/2024$5.77$5.62-2.60%$5.83$5.46570,937 shs$347.09 million03/13/2024$5.72$5.77+0.87%$5.78$5.48544,184 shs$356.36 million03/12/2024$5.74$5.72-0.35%$5.80$5.46641,727 shs$353.27 million03/11/2024$6.35$5.74-9.61%$6.50$5.67847,832 shs$354.50 million03/08/2024$6.22$6.35+2.09%$6.54$6.23518,421 shs$392.18 million03/07/2024$6.02$6.22+3.32%$6.33$6.03465,429 shs$384.15 million03/06/2024$6.22$6.02-3.22%$6.31$5.90557,065 shs$371.80 million03/05/2024$6.26$6.22-0.64%$6.36$6.09430,077 shs$384.15 million03/04/2024$6.55$6.26-4.43%$6.68$6.16538,629 shs$386.62 million03/01/2024$6.36$6.55+2.99%$6.74$6.35625,609 shs$404.53 million02/29/2024$6.56$6.36-3.05%$6.71$6.33485,463 shs$392.79 million02/28/2024$6.84$6.56-4.09%$7.01$6.53563,728 shs$405.15 million02/27/2024$6.11$6.84+11.95%$6.85$6.16902,377 shs$422.45 million02/26/2024$5.71$6.11+7.01%$6.12$5.64886,025 shs$377.35 million02/23/2024$5.54$5.71+3.07%$5.77$5.48352,891 shs$352.65 million02/22/2024$5.64$5.54-1.77%$5.70$5.45395,823 shs$342.15 million02/21/2024$5.78$5.64-2.42%$5.86$5.60333,589 shs$348.33 million02/20/2024$5.82$5.78-0.69%$5.90$5.67563,564 shs$356.97 million02/19/2024$5.82$5.82$5.84$5.56596,500 shs$359.44 million Related Companies: Neoleukin Therapeutics Stock Price Chart Contineum Therapeutics Stock Price Chart Aquestive Therapeutics Stock Price Chart Rani Therapeutics Stock Price Chart Enanta Pharmaceuticals Stock Price Chart Xeris Biopharma Stock Price Chart CorMedix Stock Price Chart Ventyx Biosciences Stock Price Chart MacroGenics Stock Price Chart Nature's Sunshine Products Stock Price Chart Receive INZY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inozyme Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INZY) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyShocking: One AI startup's revenue could surge 4,735%Manward PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts"The Biggest Drug Ever" Is ComingBehind the Markets4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inozyme Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.